133 related articles for article (PubMed ID: 6093712)
1. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
[TBL] [Abstract][Full Text] [Related]
2. Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma.
Takenaka K; Kanematsu T; Shimada M; Sugimachi K
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1191-5. PubMed ID: 2548869
[TBL] [Abstract][Full Text] [Related]
3. [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Akiharu W; Higashi T; Kobayashi M; Nakatsukasa H; Fujiwara M; Shiota T; Yamauchi Y; Ito T; Yamamoto H; Nagashima H
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2506-12. PubMed ID: 6095760
[TBL] [Abstract][Full Text] [Related]
4. [1-Hexylcarbamoyl-5-fluorouracil (HCFU) effective in hepatocellular carcinoma metastatic to the lungs--a case report].
Higashi H; Takenaka K; Kanematsu T; Matsumata T; Yoshida Y; Sugimachi K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2956-9. PubMed ID: 2821925
[TBL] [Abstract][Full Text] [Related]
5. [Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
Onji M; Kondo H; Yamashita Y; Ohta Y; Mori K; Fuse M
Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2063-72. PubMed ID: 3005446
[No Abstract] [Full Text] [Related]
6. [A case of hepatocellular carcinoma (HCC) with lung metastasis which responded to chemotherapy with a single use of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
Kanda Y; Akazawa S; Futatsugi K; Fujiki T; Saifuku K; Yamamoto K; Suzuki F; Nakajima T; Naoi Y; Muraoka M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):269-72. PubMed ID: 2537606
[TBL] [Abstract][Full Text] [Related]
7. [5-FU and HCFU concentrations in serum and tissues in hepatocellular carcinoma after HCFU oral administration].
Suenaga M
Gan No Rinsho; 1988 May; 34(6):744-8. PubMed ID: 2837592
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
Koyama Y; Koyama Y
Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
[TBL] [Abstract][Full Text] [Related]
9. [HCFU and 5-fluorouracil levels in the blood and tissue of hepatocellular carcinoma after oral administration of HCFU].
Mori M; Hamazaki K; Mimura H; Orita K
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3763-8. PubMed ID: 2556972
[TBL] [Abstract][Full Text] [Related]
10. Oral HCFU for prevention of hepatic metastasis in an experimental colorectal carcinoma.
Ito K; Wang L; Ye C; Ando H; Hibi K; Hidemura K; Akiyama S; Kasai Y; Nakao A
Anticancer Res; 2001; 21(2A):899-904. PubMed ID: 11396182
[TBL] [Abstract][Full Text] [Related]
11. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1-hexylcarbamoyl-5-fluorouracil on spontaneous mammary adenocarcinoma of mice.
Tokuzen R; Iigo M; Hoshi A; Kuretani K
Gan; 1980 Oct; 71(5):724-8. PubMed ID: 7227721
[TBL] [Abstract][Full Text] [Related]
13. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
[TBL] [Abstract][Full Text] [Related]
14. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
Sakurai K; Yoshiga K; Tsumura M; Takada K
Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
[TBL] [Abstract][Full Text] [Related]
15. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of HCFU therapy of head and neck cancer].
Taketa C
Gan To Kagaku Ryoho; 1986 May; 13(5):1846-50. PubMed ID: 3707146
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma.
Yamamoto M; Arii S; Sugahara K; Tobe T
Br J Surg; 1996 Mar; 83(3):336-40. PubMed ID: 8665186
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
19. [Oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in repeated arterial bolus chemotherapy in metastatic liver cancer of humans--preliminary randomized trial].
Kohno H; Chang YC; Nagasue N; Nakamura T; Yukaya H; Ogawa Y; Sasaki K; Takahashi M
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1371-3. PubMed ID: 1906265
[No Abstract] [Full Text] [Related]
20. [Clinical study of HCFU and radiation therapy for head and neck cancer].
Honda T
Gan To Kagaku Ryoho; 1983 Mar; 10(3):799-804. PubMed ID: 6881999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
